New York Life Investment Management’s Gentex GNTX Stock Holding History

New York Life Investment Management’s Portfolio GNTX Stock Details GNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-23,694	Closed	-$521K	–	817
2025 Q2	$521K	Sell	23,694 -590	-2%	-$12.9K	﹤0.01%	756
2025 Q1	$566K	Sell	24,284 -151	-0.6%	-$3.86K	0.01%	761
2024 Q4	$702K	Sell	24,435 -2,480	-9%	-$74.2K	0.01%	737
2024 Q3	$799K	Sell	26,915 -1,543	-5%	-$47.9K	0.01%	739
2024 Q2	$959K	Buy	28,458 +4,934	+21%	+$170K	0.01%	694
2024 Q1	$850K	Sell	23,524 -1,008	-4%	-$34.9K	0.01%	718
2023 Q4	$801K	Sell	24,532 -344	-1%	-$10.6K	0.01%	711
2023 Q3	$809K	Buy	24,876 +13,161	+112%	+$422K	0.01%	674
2023 Q2	$343K	Buy	+11,715	New	+$323K	﹤0.01%	1179

Other funds holding GNTX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BAM

Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

New York Life Investment Management's GNTX Position: Q3 2025 in Review

New York Life Investment Management sold out of Gentex (GNTX) in Q3 2025, closing a stake of 23,694 shares — an estimated $521K sold.

New York Life Investment Management first reported a position in GNTX in Q2 2023 and held it in 9 quarters. The position peaked at $959K in Q2 2024. 510 funds tracked by Wall St. Rank hold GNTX as of Q3 2025.

New York Life Investment Management reported no remaining Gentex position as of Q3 2025 after selling out during the quarter.
New York Life Investment Management sold 23,694 Gentex shares in Q3 2025, an estimated $521K.
New York Life Investment Management first reported a position in Gentex in Q2 2023 and held it in 9 quarters.
New York Life Investment Management's Gentex position peaked at $959K in Q2 2024.
510 funds tracked by Wall St. Rank held Gentex as of Q3 2025.

Based on New York Life Investment Management's 13F filing for Q3 2025, filed 6 Nov 2025.